MyFinsight
Home
Blog
About
Contact
Maturities of marketable
securities
$50,147K
Exercise of common stock
options
$2,213K
Net cash provided by
(used in) investing...
$24,820K
Net cash provided by
financing activities
$1,893K
Canceled cashflow
$25,327K
Canceled cashflow
$320K
Net increase in
cash, cash...
$4,873K
Canceled cashflow
$21,840K
Purchases of marketable
securities
$25,327K
Stock-based compensation
expense
$6,553K
Accounts payable
$1,209K
Prepaid expenses and
other current assets
-$740K
Non-cash operating lease
expense
$489K
Depreciation expense
$154K
Payment of deferred
offering costs
$320K
Net cash used in
operating activities
-$21,840K
Canceled cashflow
$9,145K
Net loss
-$26,779K
Accrued expenses and
other current...
-$3,463K
Operating lease
liabilities
-$543K
Amortization of discount on
marketable securities
$200K
Back
Back
Cash Flow
Sionna Therapeutics, Inc. (SION)
Sionna Therapeutics, Inc. (SION)
source: myfinsight.com